ACORN IQ
Technology/Service ProviderAt ACORN IQ, we are proud to be at the forefront of driving positive change in the healthcare industry. Through our patient recruitment services, we connect researchers with…

Almac Clinical Technologies empowers the biopharmaceutical industry with a comprehensive suite of interoperable eClinical solutions. Our unified modular platform, Almac Trial Coordinator™ , integrates industry‑leading IRT with advanced eCOA, eConsent, and Visit Management—streamlining site, participant, and supply management in one ecosystem. We engineer qua lity into every step, combining real‑time patient and site data with sophisticated supply management to give sponsors, sites, and CROs the visibility and control needed for confident, data‑driven decisions. With a focus on compliance, precision, and reliability, we support global participant engagement and complex clinical trial designs. Backed by expertise, energy, and commitment, Almac is a trusted partner in accelerating drug development and transforming clinical research. About Almac Clinical Technologies • 25+ years of dedicated IRT experience • 700+ employees • Offices in the UK, US, Japan, and Singapore Almac Clinical Technologies is part of Almac Group , a global, privately owned drug development services provider offering integrated solutions to 600+ biopharma companies worldwide.
At ACORN IQ, we are proud to be at the forefront of driving positive change in the healthcare industry. Through our patient recruitment services, we connect researchers with…
ResearchSmart is the leading collaborative platform for doing meaningful research. Seamlessly develop protocols, warehouse data and conduct analysis in a single platform. We offer…
Almac provides the most comprehensive global clinical supply chain solution in the marketplace. Guided by our extensive supply experience, we provide the physical resources and…
Aparito’s mission is to digitise clinical trials and accelerate drug development for patients living with life-limiting diseases by supporting patient-centric clinical trials for…